view low-bandwidth site

Product Pipeline

An extensive set of assays for a range of infectious and non-infectious diseases—with targets including DNA/RNA, proteins, and cells—are in the development pipeline for the EOSCAPE platform.

  • EOSCAPE-HBV DNA.
    Quantitative assay measuring HBV DNA in circulating blood.
  • EOSCAPE-HIV RNA PLUS.
    Qualitative assay measuring HIV RNA and DNA in circulating blood for diagnosing acute HIV infection and for early infant diagnosis.
  • EOSCAPE-TB.
    Quantitative assay measuring TB bacterial DNA/RNA in sputum.
  • EOSCAPE-TB-DST.
    Qualitative assay for identifying resistance to rifampicin and fluoroquinolone from sputum. For use in a reflex testing model with the EOSCAPE-TB.
  • EOSCAPE-HBV DNA PLUS.
    Quantitative assay simultaneously measuring HBV DNA in circulating blood and a panel of protein biomarkers relevant to HBV diagnosis and monitoring.
  • EOSCAPE-HCV RNA.
    Qualitative assay detecting presence of each of the six major HCV genotypes in whole blood.
  • EOSCAPE-STD.
    Quantitative assay detecting chlamydia and gonorrhea in vaginal swabs.